Hypoparathyroidism

E4_HYPOPARA

hypoparathyroidism: Hypoparathyroidism is is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (PTH). Common signs and symptoms includeabdominal pain, brittle nails, cataracts, dry hair and skin,muscle cramps,tetany, pain in the face, legs, and feet, seizures, tingling sensation,and weakened tooth enamel (in children). It may be caused byinjury to the parathyroid glands (e.g., during surgery). Other causes, include low blood magnesium levels, a side effect of radioactive iodine treatment for hyperthyroidism , metabolic alkalosis , DiGeorge syndrome , and type I polyglandular autoimmune syndrome . The goal of treatment is to restore the calcium and mineral balance in the body.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E20 Hospital discharge: ICD-9 — 2521 Hospital discharge: ICD-8 — 2521 Cause of death: ICD-10 — E20 Cause of death: ICD-9 — 2521 Cause of death: ICD-8 — 2521 KELA reimbursements: KELA codes — 106 Medicine purchases: ATC — H05AA 4 out of 7 registries used, show all original rules.	1529
4. Check minimum number of events Min. number of events 3	1529
5. Include endpoints None	1529
6. Filter based on genotype QC (FinnGen only)	1386

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E20-E35
Name in latin: Hypoparathyreoidismus

NAME	E4_HYPOPARA
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E20
HD_ICD_9	2521
HD_ICD_8	2521
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E20
COD_ICD_9	2521
COD_ICD_8	2521
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	106
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	H05AA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypoparathyroidism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8240	6591	1583
Only index persons	6794	5561	1233
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.04
Only index persons	0.18	0.20	0.05
Median age at first event (years)
Whole population	60.83	61.53	57.93
Only index persons	60.57	61.51	56.35

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1386	1119	267
Unadjusted period prevalence (%)	0.34	0.40	0.12
Median age at first event (years)	60.87	61.19	59.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1425: Matched controls
14250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

16.0

321.4

298

231

BAA60

NOMESCO Finland

Total thyroidectomy

19.5

320.9

265

165

A12AA04

ATC

calcium carbonate; oral

135.0

307.7

378

104

Kela drug reimbursment

Thyroid insufficiency

9.4

307.7

480

727

E83.51

ICD-10 Finland

Hypocalcemia

90.5

307.7

209

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

339.4

307.7

296

106

Kela drug reimbursment

Hypoparathyroidism

+∞

307.7

545

H05AA02

ATC

teriparatide; parenteral

11136.7

307.7

644

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

101.9

307.7

209

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

32.6

307.7

299

115

318

Kela drug reimbursment

Teriparatide

2926.3

307.7

644

A11CC03

ATC

alfacalcidol; systemic

67.3

307.7

453

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

9.2

288.6

420

617

M05BX04

ATC

denosumab; parenteral

8.8

283.0

431

667

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

18.4

280.0

236

152

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

7.6

265.7

1106

4450

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

15.5

253.4

234

178

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

26.9

240.8

169

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

27.8

235.3

163

A11CC02

ATC

dihydrotachysterol; oral

635.9

225.0

217

L95

ICPC

Osteoporosis

8.5

206.0

302

438

M81.9

ICD-10 Finland

Osteoporosis, unspecified

7.9

199.7

312

486

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

2060.6

182.3

173

M05BA04

ATC

alendronic acid; oral

5.6

177.5

422

989

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.3

157.5

390

939

H02AB09

ATC

hydrocortisone; systemic

17.7

157.0

131

H03AA01

ATC

levothyroxine sodium; systemic

4.0

146.9

706

2790

A12AA06

ATC

calcium lactate gluconate; oral

+∞

146.4

138

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

11.0

135.2

151

152

M05BA07

ATC

risedronic acid; oral

7.9

130.7

192

274

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

62.2

127.6

E20.8

ICD-10 Finland

Other hypoparathyroidism

+∞

127.0

120

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

+∞

118.4

112

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

247.6

112.5

114

E21.0

ICD-10 Finland

Primary hyperparathyroidism

32.4

109.4

L04AX01

ATC

azathioprine; systemic

7.4

108.6

169

256

M81.4

ICD-10 Finland

Drug-induced osteoporosis

32.4

100.1

3025

Kela drug reimbursment

Calcium carbonate

38.1

100.1

L01BA01

ATC

methotrexate; systemic

6.3

86.9

156

273

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

47.1

84.9

M80

ICD-10 Finland

Osteoporosis with pathological fracture

15.1

84.9

EP1AE

NOMESCO Finland

Neck ultrasound examination

5.0

84.5

199

446

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

28.0

79.4

L04AX03

ATC

methotrexate; systemic

3.8

76.8

279

865

E83.50

ICD-10 Finland

Hypercalcemia

12.3

76.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.5

73.6

306

1035

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

5.2

72.0

160

340

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

71.9

399

1603

L88

ICPC

Rheumatoid/seropositive arthritis

5.2

71.5

159

338

L04AA13

ATC

[U] leflunomide

7.1

71.3

112

170

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

9.4

69.3

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

29.0

67.0

P01BA02

ATC

hydroxychloroquine; oral

3.6

64.9

247

785

M05BX03

ATC

strontium ranelate; oral

15.2

64.2

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.2

63.8

186

490

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.0

62.4

193

531

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.0

62.2

115

206

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

60.7

881

5582

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.2

60.3

107

184

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.9

59.3

194

555

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

5.1

59.2

133

284

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

+∞

58.8

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

7.2

58.1

131

L04AA01

ATC

[U] ciclosporin

11.1

57.8

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

4.8

56.9

138

314

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

56.8

415

1899

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

5.8

54.5

103

188

L04AA06

ATC

mycophenolic acid; systemic

9.6

53.1

NF1AA

NOMESCO Finland

Hip X-ray examination

3.2

53.0

249

895

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

8.3

52.7

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

9.9

50.7

C03CA01

ATC

furosemide; systemic

2.3

50.0

596

3375

M81.8

ICD-10 Finland

Other osteoporosis

10.4

49.8

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

49.6

367

1676

H02AB06

ATC

prednisolone; systemic

2.3

49.4

828

5391

127

Kela drug reimbursment

Transplant complication

12.3

49.0

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

494.1

48.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.1

48.4

228

819

ZX120

NOMESCO Finland

Intravenous

3.2

48.3

221

780

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

46.7

615

3604

N02AX02

ATC

tramadol; systemic, rectal

2.2

46.4

728

4574

N02AA05

ATC

oxycodone; systemic

2.5

46.2

390

1887

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.1

45.0

207

731

M05BA06

ATC

ibandronic acid; systemic

5.1

44.1

195

SPAT1229

SPAT

Assessment of need for aid

3.1

43.0

196

688

SPAT1262

SPAT

Handing over of treatment supplies

2.5

42.5

334

1557

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

42.2

451

2406

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

41.6

557

3249

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

41.0

279

1212

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

5.1

41.0

184

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

15.4

40.9

J01MA12

ATC

levofloxacin; systemic

2.4

40.7

340

1627

J01FF01

ATC

clindamycin; systemic

2.2

40.6

478

2646

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.8

40.3

132

375

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

5.2

40.3

175

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

7.7

40.1

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

205.6

39.0

H02AB04

ATC

methylprednisolone; systemic

2.5

39.0

290

1313

M01CB01

ATC

sodium aurothiomalate; parenteral

7.0

38.8

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

38.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

38.5

406

2140

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

38.1

264

1154

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

37.9

452

2503

L76

ICPC

Fracture: other

4.3

37.6

101

248

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

37.0

421

2283

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

37.0

227

934

L04AB01

ATC

etanercept; parenteral

6.9

36.7

S97

ICPC

Chronic ulcer skin

3.2

36.7

154

513

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

7.1

36.6

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

36.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

36.4

236

997

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

4.6

36.4

203

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.3

36.2

242

H26.3

ICD-10 Finland

Drug-induced cataract

12.3

36.0

N03AX16

ATC

[U] pregabalin

2.2

35.8

428

2363

L04AD01

ATC

ciclosporin; systemic

6.8

35.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

35.4

301

1442

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.0

35.2

685

4511

L28

ICPC

Limited function/disability (L)

2.2

35.0

401

2175

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

34.0

327

1649

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

57.2

33.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

33.2

239

1059

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.8

33.2

164

NF3AA

NOMESCO Finland

Femur X-ray examination

4.8

33.0

169

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.5

32.5

116

348

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

32.5

223

966

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

32.0

162

600

M81.5

ICD-10 Finland

Idiopathic osteoporosis

7.7

32.0

GD1AD

NOMESCO Finland

Thorax CT examination

3.1

31.9

143

494

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

31.9

205

860

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.0

31.5

245

E20

ICD-10 Finland

Hypoparathyroidism

+∞

31.4

N03AX12

ATC

[U] gabapentin; oral

2.2

31.1

309

1574

ZXD05

NOMESCO Finland

Urgent procedure

2.0

30.9

471

2817

A07EC01

ATC

sulfasalazine; oral, rectal

2.8

30.9

169

652

M05BA01

ATC

etidronic acid; systemic

9.7

30.7

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

9.2

30.4

H02AB07

ATC

prednisone; oral

2.3

30.0

264

1276

M54.5

ICD-10 Finland

Low back pain

1.9

30.0

611

4022

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

29.3

29.9

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

9.7

29.8

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

29.8

604

3968

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

4.7

29.7

155

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

7.2

29.4

ZZH31

NOMESCO Finland

Bone allograft, small pieces

8.5

29.2

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

297.8

28.9

SPAT1254

SPAT

Administration of medicine

2.2

28.8

280

1409

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.5

28.7

101

300

H02AA02

ATC

fludrocortisone; oral

9.9

28.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

28.3

269

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

28.2

577

3784

E0000UV, ,

ATC

1.9

28.1

678

4682

S72.3

ICD-10 Finland

Fracture of shaft of femur

7.6

28.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

28.0

506

3187

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.1

27.9

206

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

286.9

27.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

27.8

651

4449

X58

ICD-10 Finland

Exposure to other specified factors

2.3

27.7

251

1225

AA1AD

NOMESCO Finland

CT of head and brain

1.9

27.7

509

3220

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.0

27.7

212

H03BB01

ATC

carbimazole; oral

3.4

27.6

106

333

R50.9

ICD-10 Finland

Fever, unspecified

2.2

27.6

266

1333

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

27.0

128

456

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

27.0

184

791

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.7

26.8

139

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

26.7

109

356

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.0

26.6

120

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.9

26.4

UJF32

NOMESCO Finland

Coloscopy

1.9

26.4

450

2769

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.8

26.4

146

566

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

26.3

677

4738

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

23.7

26.2

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

23.7

26.2

105

Kela drug reimbursment

Adrenal cortical hypofunction

+∞

26.1

W19

ICD-10 Finland

Unspecified fall

2.4

26.1

193

861

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.7

26.1

235

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

26.1

228

1095

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.8

25.9

227

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

74.1

25.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

25.8

152

608

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.7

25.8

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

25.8

116

401

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

25.6

167

702

J01MA02

ATC

ciprofloxacin; systemic

1.8

25.6

598

4054

ZXA10

NOMESCO Finland

Bilateral

2.0

25.6

339

1911

A02BC05

ATC

esomeprazole; systemic

1.8

25.5

655

4566

XG410

NOMESCO Finland

Flow-volume spirometry

3.6

25.5

253

S72.2

ICD-10 Finland

Subtrochanteric fracture

8.8

25.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

25.1

393

2345

R03BB04

ATC

tiotropium bromide; inhalant

2.4

25.0

182

806

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

24.8

207

973

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.9

24.7

124

456

L04AB04

ATC

adalimumab; parenteral

4.7

24.7

124

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.4

24.5

280

A07AA02

ATC

nystatin; oral

2.8

24.5

133

510

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

24.4

138

540

A46

ICD-10 Finland

Erysipelas

2.2

24.3

245

1244

WZC30

NOMESCO Finland

Teaching

2.1

24.3

291

1578

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

57.1

24.1

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.0

24.0

107

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

23.9

292

1595

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.8

23.7

203

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

23.6

204

972

5BA08, ,

NOMESCO Finland

9.5

23.6

NH1AD

NOMESCO Finland

Ankle and foot CT

4.5

23.5

133

SPAT1255

SPAT

Intravenous administration of medicine

2.8

23.5

128

491

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.6

23.3

234

2506

FHL

Thyroidectomy

28.8

23.2

25219

ICD-8 Finland

Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD

+∞

23.0

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

22.9

170

758

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

23.3

22.6

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

22.6

340

1992

WX204

NOMESCO Finland

Axillary plexus blockaced

3.6

22.6

224

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.4

22.6

163

718

S52.0

ICD-10 Finland

Fracture of upper end of ulna

4.7

22.5

113

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

22.5

216

1074

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

22.4

275

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

4.4

22.4

134

E87.6

ICD-10 Finland

Hypokalaemia

3.2

22.3

297

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

22.2

198

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

22.1

279

1537

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

22.1

144

604

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

22.1

449

2890

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

22.1

111

408

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.2

22.0

299

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

21.9

296

1670

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.3

21.8

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.3

21.8

137

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

20.4

21.7

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

6.8

21.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

21.7

109

401

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

21.6

160

L03

ICPC

Low back symptom/complaint

1.8

21.6

491

3263

A02BC02

ATC

pantoprazole; systemic

1.8

21.5

1044

8566

SPAT1301

SPAT

No procedures

1.8

21.4

506

3399

J46

ICD-10 Finland

Status asthmaticus

3.7

21.3

189

R03AK08

ATC

formoterol and beclometasone; inhalant

3.0

21.3

343

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

21.3

192

930

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

21.2

234

1226

TK800

NOMESCO Finland

Hemodialysis

6.2

21.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

21.2

254

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.8

21.1

172

C03DA01

ATC

spironolactone; oral

2.1

21.0

217

1109

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

16.9

21.0

ZX114

NOMESCO Finland

Intramuscular

5.5

21.0

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

+∞

20.9

R53

ICD-10 Finland

Malaise and fatigue

1.8

20.8

419

2682

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.9

20.7

165

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

4.9

20.7

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

20.6

160

727

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.8

20.5

104

384

J01DB01

ATC

cefalexin; oral

2.0

20.4

1193

10271

R13

ICD-10 Finland

Dysphagia

2.5

20.3

141

609

N06AX21

ATC

duloxetine; oral

2.1

20.2

216

1117

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

20.2

742

5591

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.7

20.2

182

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

6.5

20.1

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

20.1

178

E21.2

ICD-10 Finland

Other hyperparathyroidism

58.4

19.9

R06.0

ICD-10 Finland

Dyspnoea

1.7

19.8

455

3018

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

19.8

129

541

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

4.5

19.8

113

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.8

19.7

104

392

NDG30

NOMESCO Finland

Fusion of wrist, total

8.3

19.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

19.6

299

1750

SPAT1263

SPAT

Sampling

1.7

19.6

635

4620

A06AD11

ATC

lactulose; oral

2.0

19.5

258

1440

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

19.4

149

673

B01AB05

ATC

enoxaparin; parenteral

1.7

19.4

508

3489

A07AA09

ATC

vancomycin; oral

5.2

19.4

SPAT1211

SPAT

Application of soft bandage

2.3

19.2

159

742

SPAT1216

SPAT

Assessment of functional ability

1.9

19.1

286

1663

N18.8

ICD-10 Finland

Other chronic renal failure

4.5

19.0

104

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

19.0

172

833

M54

ICD-10 Finland

Dorsalgia

2.1

19.0

210

1100

Z2446

NOMESCO Finland

Social worker

2.6

18.9

118

484

BBA20

NOMESCO Finland

Exploration of parathyroid gland

+∞

18.8

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

18.8

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.0

18.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

18.7

102

391

M19.2

ICD-10 Finland

Other secondary arthrosis

5.2

18.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

18.7

199

1027

J45.8

ICD-10 Finland

Mixed asthma

3.4

18.6

207

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

192.4

18.6

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.0

18.4

137

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

5.4

18.3

S22.3

ICD-10 Finland

Fracture of rib

2.5

18.3

122

517

A28

ICPC

Limited function/disability NOS

1.8

18.3

335

2073

Z3226

NOMESCO Finland

Physiotherapist

1.9

18.3

295

1756

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

18.0

168

823

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

53.2

18.0

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

18.0

264

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.1

17.7

119

A01AB09

ATC

miconazole; local oral

2.2

17.6

164

803

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

17.6

567

4087

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.7

17.4

382

S18

ICPC

Laceration/cut

1.6

17.4

719

5503

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

17.4

587

4277

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.1

17.4

SPAT1310

SPAT

Counselling related to known health issue

1.7

17.3

485

3368

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

17.3

167

TQW80

NOMESCO Finland

Local dermatologic skincare

3.6

17.3

167

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

17.3

303

X57

ICD-10 Finland

Unspecified privation

4.1

17.3

121

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

17.2

326

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

17.2

251

1444

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

17.2

218

L75

ICPC

Fracture: femur

4.7

17.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

17.0

635

4733

OAB50, ,

SPAT

2.3

17.0

143

671

Z94.0

ICD-10 Finland

Kidney transplant status

13.4

17.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

16.9

214

1173

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

16.9

119

517

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

16.8

165

825

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

4.1

16.7

115

WZA10

NOMESCO Finland

Extensive medical or dental certificate

5.1

16.7

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

16.7

201

E31.00

ICD-10 Finland

APECED syndrome

+∞

16.7

BBA50

NOMESCO Finland

Total parathyroidectomy

+∞

16.7

E23.03

ICD-10 Finland

Lack of ACTH

+∞

16.7

RD210, ,

NOMESCO Finland

4.7

16.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

16.6

299

SXC03

NOMESCO Finland

Other oral or dental procedure

5.6

16.5

J04AB02

ATC

rifampicin; systemic

5.6

16.5

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.1

16.5

112

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

16.4

289

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.7

16.4

149

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

5.3

16.3

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

5.3

16.3

J01MA14

ATC

moxifloxacin; systemic

2.2

16.3

146

703

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.4

16.3

174

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.9

16.2

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

16.2

230

1310

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.5

16.2

NA2AD

NOMESCO Finland

Thoracic spine CT examination

6.9

16.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

30.4

16.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

15.9

122

550

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

15.9

168

862

R60.0

ICD-10 Finland

Localized oedema

1.9

15.8

224

1274

R4180

NOMESCO Finland

Podiatric therapy

5.0

15.7

WW200

NOMESCO Finland

Immunization

3.7

15.7

139

A02BA02

ATC

ranitidine; systemic

1.8

15.7

309

1943

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

15.7

307

1928

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

15.7

231

1331

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

15.7

M48.0

ICD-10 Finland

Spinal stenosis

1.9

15.6

221

1257

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

15.5

123

563

R52.2

ICD-10 Finland

Other chronic pain

2.8

15.5

304

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

15.5

141

683

A01

ICPC

Pain general/multiple sites

2.0

15.5

195

1066

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

15.4

281

1726

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

15.4

131

617

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

15.4

376

XG466

NOMESCO Finland

Sleep oxymetry

3.5

15.3

151

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

15.3

224

1286

NB1AD

NOMESCO Finland

Shoulder CT examination

3.7

15.3

132

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.1

15.3

105

Z3231

NOMESCO Finland

Registered nurse

1.7

15.3

402

2732

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

15.1

113

504

N05CF01

ATC

zopiclone; oral

1.6

15.1

496

3558

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

15.0

374

R03AC02

ATC

salbutamol; inhalant

1.6

15.0

807

6479

NHQ40

NOMESCO Finland

Amputation of toe

4.9

15.0

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.4

14.9

164

R03DA04

ATC

theophylline; systemic, rectal

2.6

14.9

346

S32.5

ICD-10 Finland

Fracture of pubis

5.6

14.8

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.4

14.7

NCJ64

NOMESCO Finland

Other internal fixation of fracture of forearm

5.4

14.7

UKC02

NOMESCO Finland

Cystoscopy

1.9

14.7

209

1189

S82.0

ICD-10 Finland

Fracture of patella

3.8

14.7

122

WX002

NOMESCO Finland

Sedation and analgesia

1.7

14.6

302

1920

XF640, ,

NOMESCO Finland

3.3

14.6

171

WX882

NOMESCO Finland

High dependency care

3.3

14.6

166

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.4

14.6

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

14.5

123

B01AA03

ATC

warfarin; systemic

1.8

14.4

264

1622

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.3

14.4

R11

ICD-10 Finland

Nausea and vomiting

2.0

14.4

162

850

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

14.3

132

642

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.0

14.3

ZZA00

NOMESCO Finland

Split skin graft

3.3

14.3

163

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

14.3

221

1291

EBA10

NOMESCO Finland

Operative extraction of tooth

2.0

14.2

164

868

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

6.2

14.2

327

Kela drug reimbursment

strontium ranelate

42.9

14.1

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

14.1

349

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

14.1

121

572

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

14.1

104

461

K07

ICPC

Swollen ankles/oedema

2.4

14.1

430

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

6.8

14.0

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.6

14.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

14.0

535

3957

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.9

14.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

14.0

299

1918

SPAT1260

SPAT

Consultation of another employee

1.7

14.0

275

1724

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

5.3

13.9

N02BE01

ATC

paracetamol; systemic, rectal

2.1

13.9

1300

11876

L17

ICPC

Foot/toe symptom/complaint

1.6

13.9

487

3532

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

13.9

230

1371

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

13.9

103

458

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.5

13.8

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.7

13.7

123

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

13.7

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

5.8

13.7

SPAT1325

SPAT

Vaccination

1.6

13.7

507

3721

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

13.7

373

C07AB07

ATC

bisoprolol; oral

1.5

13.6

720

5710

NDG74

NOMESCO Finland

Fusion of first IP joint

14.9

13.6

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

5.5

13.6

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

13.5

176

971

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

13.5

217

JN4CD

NOMESCO Finland

Very extensive body CT

2.9

13.5

234

L99

ICPC

Musculoskeletal disease other

3.2

13.4

165

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.3

13.4

160

R4120

NOMESCO Finland

Occupational therapy

2.2

13.2

111

520

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.0

13.2

198

A10AB05

ATC

insulin aspart; parenteral

2.2

13.2

116

554

ZXE00

NOMESCO Finland

One hour or less

1.5

13.1

545

4092

K22.2

ICD-10 Finland

Oesophageal obstruction

6.0

13.1

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

13.0

102

464

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

13.0

302

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.7

13.0

267

WX202

NOMESCO Finland

Supraclavicular plexus blockade

4.2

13.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

13.0

376

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.0

12.9

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

19.2

12.9

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

12.9

542

4076

SAA04

NOMESCO Finland

Special examination of mouth

2.4

12.9

377

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

12.9

182

1031

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

12.9

230

1400

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.9

12.9

212

T99

ICPC

Endocr/metab/nutrit disease other

3.9

12.8

SPAT1153

SPAT

Removal of sutures

1.6

12.8

471

3439

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

12.8

144

755

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

12.7

431

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.7

12.6

111

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

6.0

12.6

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.0

12.6

198

N05CD07

ATC

temazepam; oral

1.8

12.6

187

1076

A12BA01

ATC

potassium chloride; oral

2.5

12.6

338

NC2AA

NOMESCO Finland

Forearm X-ray examination

4.0

12.5

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

12.5

107

506

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

131.1

12.5

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.6

12.4

117

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

3.6

12.4

117

D68.8

ICD-10 Finland

Other specified coagulation defects

5.1

12.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

12.4

428

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.5

12.4

122

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.5

12.4

122

JN4BD

NOMESCO Finland

Extensive body CT

1.9

12.4

156

850

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.6

12.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

12.4

132

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

12.3

205

1221

N06AA09

ATC

amitriptyline; systemic

1.9

12.3

168

941

N03AE01

ATC

clonazepam; systemic

2.3

12.3

417

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.5

12.3

118

UJF92

NOMESCO Finland

Capsular endoscopy

3.5

12.3

118

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

12.2

120

598

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

4.0

12.2

J02AC01

ATC

fluconazole; systemic

1.5

12.2

596

4612

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

16.0

12.1

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

12.1

105

498

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.1

12.1

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.5

12.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.6

12.1

271

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

12.1

407

T71

ICPC

Malignant neoplasm thyroid

26.9

12.1

WX402

NOMESCO Finland

General anaesthesia

1.6

12.0

315

2120

L04AD02

ATC

tacrolimus; systemic

10.1

12.0

L84

ICD-10 Finland

Corns and callosities

2.7

12.0

249

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.5

12.0

120

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.7

12.0

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

11.9

162

906

H05BX01

ATC

cinacalcet; oral

47.1

11.9

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

47.1

11.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

11.9

306

2051

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

11.9

433

3147

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

11.8

110

538

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

11.7

430

3126

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

4.4

11.7

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

11.7

107

519

NDG76

NOMESCO Finland

Fusion of DIP joint

5.0

11.7

RS222, ,

NOMESCO Finland

4.5

11.7

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.3

11.7

375

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

12.7

11.6

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

12.7

11.6

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.9

11.6

196

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

11.6

991

8551

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

11.6

133

702

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.0

11.6

3AC01, ,

NOMESCO Finland

5.3

11.6

R03DC01

ATC

zafirlukast; oral

3.7

11.5

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

9.3

11.5

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

+∞

11.5

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.4

11.4

119

R02

ICPC

Shortness of breath/dyspnoea

1.7

11.4

222

1382

RS221, ,

NOMESCO Finland

4.2

11.4

A04

ICPC

Weakness/tiredness general

1.7

11.3

254

1643

L02

ICPC

Back symptom/complaint

1.8

11.3

165

944

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

11.3

199

1205

G47.3

ICD-10 Finland

Sleep apnoea

1.6

11.3

284

1891

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

11.3

269

1767

XKD00

NOMESCO Finland

Uroflowmetry

1.9

11.3

141

767

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

9.7

11.3

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.9

11.2

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.0

11.2

167

K07.60

ICD-10 Finland

Snapping jaw

2.3

11.2

382

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

11.2

710

5758

9284

FHL

Wrist ossification surgery

25.2

11.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

11.1

131

WX892

NOMESCO Finland

Monitored bed care

2.1

11.1

111

558

SPAT1234

SPAT

Support of social functional capacity

2.2

11.1

443

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

11.3

11.1

N03AX09

ATC

lamotrigine; oral

2.5

11.1

296

JN4AD

NOMESCO Finland

Body CT examination

1.8

11.0

173

1011

N06AX11

ATC

mirtazapine; oral

1.5

11.0

500

3792

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

10.1

11.0

M01AH02

ATC

rofecoxib; oral

1.7

11.0

204

1253

ZXA00

NOMESCO Finland

Right side

1.5

11.0

391

2819

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

11.0

285

SPAT1210

SPAT

Application of cast or individual aid

2.4

10.9

323

R4190

NOMESCO Finland

Nutritional therapy

2.6

10.9

250

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

10.9

127

675

R06AE07

ATC

cetirizine; oral

1.5

10.8

630

5011

R03DC03

ATC

montelukast; oral

1.7

10.8

245

1586

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

10.8

154

874

N18.0

ICD-10 Finland

End-stage renal disease

8.9

10.8

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

10.7

109

ZZH40

NOMESCO Finland

Substitute of bone

4.8

10.7

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

28.2

10.7

L01BB01, ,

ATC

28.2

10.7

J96.1

ICD-10 Finland

Chronic respiratory failure

3.4

10.7

114

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

10.7

276

A02BC01

ATC

omeprazole; systemic

1.5

10.7

390

2823

C08CA05

ATC

nifedipine; systemic

2.2

10.7

423

E22.1

ICD-10 Finland

Hyperprolactinaemia

60.5

10.6

R4130

NOMESCO Finland

Speech therapy

2.9

10.6

167

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

10.6

105

ZY010

NOMESCO Finland

Hospital outpatient

2.4

10.6

327

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

10.5

106

534

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.9

10.5

S82.1

ICD-10 Finland

Fracture of upper end of tibia

3.3

10.4

116

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

10.4

116

TGC00

NOMESCO Finland

Bronchial lavation

3.1

10.4

147

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

+∞

10.4

25298

ICD-8 Finland

Diseases of parathyroid gland, Alii definiti

+∞

10.4

E27.2

ICD-10 Finland

Addisonian crisis

+∞

10.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

10.4

304

2093

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

10.4

349

WZA00

NOMESCO Finland

Concise certificate

2.1

10.4

101

502

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.2

10.4

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.2

10.3

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

10.3

422

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.4

10.3

112

L86

ICPC

Back syndrome with radiating pain

2.1

10.3

104

525

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.6

10.3

M05BX06

ATC

romosozumab; parenteral

23.5

10.2

H25.8

ICD-10 Finland

Other senile cataract

1.7

10.2

188

1150

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

10.2

404

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.0

10.1

155

N04BC05

ATC

pramipexole; oral

1.9

10.1

129

706

SPAT1312

SPAT

General health counselling

1.5

10.1

434

3244

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

10.1

128

700

M79.6

ICD-10 Finland

Pain in limb

1.4

10.1

653

5279

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.5

10.0

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

10.0

236

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

40.4

10.0

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

3.5

9.9

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

4.2

9.9

SFA30

NOMESCO Finland

Three-surface restoration

1.4

9.9

565

4456

SCA02

NOMESCO Finland

Preventive oral health care

1.8

9.9

147

845

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.6

9.9

232

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.9

9.9

163

H26.4

ICD-10 Finland

After-cataract

1.7

9.9

185

1138

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.1

9.8

131

E000002, ,

ATC

1.8

9.8

149

862

ZX108

NOMESCO Finland

Inhalation

8.8

9.8

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

3.0

9.8

142

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

9.8

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

9.8

116

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.1

9.7

473

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

9.7

289

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.1

9.7

132

N02AC04

ATC

dextropropoxyphene; oral

2.5

9.7

246

-50

ICPC

Medication/prescr/renewal

2.4

9.7

271

A01AB10

ATC

natamycin; local oral

2.7

9.7

199

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.2

9.7

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

9.6

357

2586

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.3

9.6

S72.4

ICD-10 Finland

Fracture of lower end of femur

4.3

9.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

9.6

520

4056

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

9.6

316

K08.3

ICD-10 Finland

Retained dental root

1.9

9.6

116

624

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.5

9.6

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

3.6

9.5

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

9.5

375

2750

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

9.5

513

3998

R52.9

ICD-10 Finland

Pain, unspecified

1.8

9.5

157

932

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.3

9.4

331

A03FA02

ATC

cisapride; oral, rectal

1.9

9.4

120

656

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

9.4

148

865

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.6

9.4

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

9.4

133

753

2581B

ICD-9 Finland

Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]

+∞

9.4

78892

ICD-8 Finland

Other general symptoms, Hypocalcaemia

+∞

9.4

H01AC01

ATC

somatropin; parenteral

+∞

9.4

A10AC01

ATC

insulin (human); parenteral

2.0

9.4

105

550

R4110, ,

SPAT

1.6

9.3

221

1444

K02.1

ICD-10 Finland

Caries of dentine

1.4

9.3

768

6447

N02BF01

ATC

gabapentin; oral

1.7

9.3

169

1030

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

9.3

126

704

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

9.6

9.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

9.3

344

2489

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

9.3

115

624

R03BA05

ATC

fluticasone; inhalant

1.6

9.2

258

1754

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

13.8

9.2

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

9.2

259

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

9.2

259

R03AC12

ATC

salmeterol; inhalant

2.3

9.2

329

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

9.2

207

1337

I50.0

ICD-10 Finland

Congestive heart failure

1.9

9.1

112

605

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

9.1

199

NG1DA

NOMESCO Finland

X-ray of knees

3.0

9.1

137

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

9.1

229

J01DA01

ATC

[U] cefalexin

1.4

9.1

843

7208

ZXA05

NOMESCO Finland

Left side

1.5

9.1

354

2586

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

9.1

458

A01AB04

ATC

amphotericin B; local oral

2.1

9.0

404

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

36.9

9.0

M01AH01

ATC

celecoxib; oral

1.6

9.0

266

1832

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.6

9.0

195

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

8.9

399

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

8.9

262

1801

3079, ,

Kela drug reimbursment

24.2

8.9

C10AC01

ATC

colestyramine; oral

2.7

8.9

184

N05BA01

ATC

diazepam; systemic, rectal

1.7

8.9

189

1201

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.4

8.9

244

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.2

8.9

320

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

8.9

166

1019

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

8.9

267

1844

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

8.9

190

J01FA06

ATC

roxithromycin; oral

1.4

8.9

557

4445

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

8.9

232

T89

ICPC

Diabetes insulin dependent

2.5

8.9

232

NF3AD

NOMESCO Finland

Femur CT

12.6

8.9

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

12.6

8.9

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

4.7

8.8

GBB00

NOMESCO Finland

Tracheostomy

4.7

8.8

P01AB01

ATC

metronidazole; oral, rectal

1.4

8.8

573

4601

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

8.8

283

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

8.8

270

1874

Z31.5

ICD-10 Finland

Genetic counselling

2.2

8.8

368

D68.9

ICD-10 Finland

Coagulation defect, unspecified

9.5

8.8

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

8.8

331

2400

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

8.7

727

6085

B82

ICPC

Anaemia other/unspecified

2.5

8.7

216

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

14.1

8.7

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

8.7

159

971

NAK40

NOMESCO Finland

Vertebroplasty

50.3

8.7

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

50.3

8.7

107

Kela drug reimbursment

Pernicious anaemia

3.2

8.7

109

H26.02

ICD-10 Finland

Presenil cataract

2.8

8.7

158

R03BA01

ATC

beclometasone; inhalant

1.6

8.7

199

1290

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

7.7

8.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

8.6

117

653

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

8.6

279

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

8.6

319

2302

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.6

8.6

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

4.8

8.6

D07AB08

ATC

desonide; topical

1.7

8.6

152

920

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

16.4

8.6

Z94.4

ICD-10 Finland

Liver transplant status

16.4

8.6

M40.1

ICD-10 Finland

Other secondary kyphosis

16.4

8.6

9289

FHL

Other measure in this category

16.4

8.6

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

8.5

319

UDC00

NOMESCO Finland

Ear microscopy

1.9

8.5

106

575

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

8.5

200

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

10.1

8.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

8.5

287

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

8.5

117

656

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

6.4

8.5

S76

ICPC

Skin infection other

2.1

8.5

414

J47

ICD-10 Finland

Bronchiectasis

2.8

8.5

143

B80

ICPC

Iron deficiency anaemia

2.6

8.5

183

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.7

8.4

166

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.8

8.4

149

NG1AD

NOMESCO Finland

Knee CT examination

3.0

8.4

127

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

8.4

110

607

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

90.6

8.4

J01DA06

ATC

[U] cefuroxime

1.6

8.4

196

1275

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

12.8

8.4

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

8.4

237

1614

B03XA01

ATC

erythropoietin; parenteral

4.9

8.4

WX213

NOMESCO Finland

Lower leg blockade

6.7

8.4

J20

ICD-10 Finland

Acute bronchitis

1.7

8.4

153

934

WX730

NOMESCO Finland

Conventional respirator

4.0

8.3

C07AA05

ATC

propranolol; systemic

1.5

8.3

278

1962

102

Kela drug reimbursment

Diabetes insipidus

+∞

8.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.3

411

3135

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.7

8.3

156

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.1

8.3

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.2

8.3

102

L29

ICPC

Musculoskeletal sympt/complt other

1.7

8.3

142

852

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.5

8.2

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.6

8.2

178

1136

R5110, ,

SPAT

1.7

8.2

149

907

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

14.6

8.2

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

14.6

8.2

L14

ICPC

Leg/thigh symptom/complaint

1.7

8.2

138

823

WX872

NOMESCO Finland

Intensive care

2.2

8.2

312

C08CA02

ATC

felodipine; oral

1.7

8.2

138

824

R01AD09

ATC

mometasone; nasal

1.4

8.2

609

4986

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

8.1

347

2573

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.6

8.1

A55

ICPC

General and Unspecified, Local injection/infiltration

4.8

8.1

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.0

8.1

119

K62.3

ICD-10 Finland

Rectal prolapse

3.2

8.1

Z01.2

ICD-10 Finland

Dental examination

1.4

8.1

627

5163

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

33.5

8.1

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

17.3

8.1

321

Kela drug reimbursment

Paricalcitol and cinacalcet

17.3

8.1

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

8.1

170

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

9.0

8.0

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.7

8.0

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.9

8.0

131

B07.9

ICD-10 Finland

Verruca simplex

2.4

8.0

219

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.9

8.0

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.7

7.9

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

13.1

7.9

S22.1

ICD-10 Finland

Multiple fractures of thoracic spine

13.1

7.9

UJD02

NOMESCO Finland

Gastroscopy

2.1

7.9

371

JN6AD

NOMESCO Finland

CT of torso and neck

3.1

7.9

100

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

7.8

313

2289

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.4

7.8

221

R06.4

ICD-10 Finland

Hyperventilation

3.5

7.8

N05BA04

ATC

oxazepam; oral

1.4

7.8

373

2821

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.3

7.8

272

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

7.8

167

R03BA08

ATC

ciclesonide; inhalant

1.8

7.8

127

750

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

9.5

7.8

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.0

7.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

7.8

493

3920

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

7.7

286

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.2

7.7

R4110

NOMESCO Finland

Physiotherapy

1.4

7.7

390

2979

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

7.7

464

A06AC51

ATC

ispaghula, combinations; oral

2.0

7.7

401

J01XX08

ATC

linezolid; systemic

6.4

7.7

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

3.9

7.7

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.2

7.7

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.5

7.7

R42

ICD-10 Finland

Dizziness and giddiness

1.4

7.7

343

2562

EB1WA, ,

NOMESCO Finland

7.5

7.7

N91.1

ICD-10 Finland

Secondary amenorrhoea

4.5

7.7

M02AA10

ATC

ketoprofen; topical

1.5

7.6

227

1561

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.8

7.6

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

7.6

169

M03BX02

ATC

tizanidine; oral

1.4

7.6

826

7151

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

18.5

7.6

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

7.6

878

7676

H02AB08

ATC

triamcinolone; systemic

6.7

7.6

R03AC03

ATC

terbutaline; inhalant

1.6

7.6

193

1281

L16

ICPC

Ankle symptom/complaint

1.6

7.6

175

1135

JJC00

NOMESCO Finland

Allogenic transplantation of liver

25.1

7.6

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.4

7.6

206

N02BF02

ATC

pregabalin; oral

1.8

7.6

104

584

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.2

7.6

309

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

7.5

504

J05AB11

ATC

valaciclovir; oral

1.5

7.5

215

1467

J01FA01

ATC

erythromycin; systemic

1.6

7.5

172

1114

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.8

7.5

136

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.7

7.5

WVA20, ,

SPAT

2.2

7.5

284

J01FA10

ATC

azithromycin; systemic

1.4

7.5

762

6525

R81

ICPC

Pneumonia

2.3

7.5

258

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

7.5

535

SPAT1252

SPAT

Overall medication plan or its review

1.9

7.5

100

557

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

7.4

338

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

7.4

233

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

80.5

7.4

E03

ICD-10 Finland

Other hypothyroidism

1.8

7.4

103

580

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

7.4

140

862

N06AX16

ATC

venlafaxine; oral

1.6

7.4

193

1288

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

7.4

182

1198

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.6

7.4

160

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

13.4

7.4

SPAT1172

SPAT

Guidance concerning hydration

2.6

7.4

166

P01BA01

ATC

chloroquine; systemic

6.0

7.4

XF402

NOMESCO Finland

ECG with work load test

1.7

7.4

145

903

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

7.4

530

B37.08

ICD-10 Finland

Other candidal stomatitis

4.0

7.4

D07AC01

ATC

betamethasone; topical

1.4

7.3

484

3865

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

7.3

619

5143

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

7.3

119

703

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

10.9

7.3

E31.0

ICD-10 Finland

Autoimmune polyglandular failure

+∞

7.3

25200

ICD-8 Finland

Diseases of parathyroid gland, Hyperparathyroidism

+∞

7.3

BBA99

NOMESCO Finland

Other operations on parathyroid gland

+∞

7.3

A12AA03

ATC

calcium gluconate; oral

+∞

7.3

25810

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction

+∞

7.3

E23.2

ICD-10 Finland

Diabetes insipidus

+∞

7.3

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.5

7.3

R33

ICD-10 Finland

Retention of urine

1.9

7.3

460

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

6.3

7.2

J01EA01

ATC

trimethoprim; systemic

1.4

7.2

405

3145

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.9

7.2

116

M05BA08

ATC

zoledronic acid; parenteral

15.8

7.2

NBB10

NOMESCO Finland

Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified

5.8

7.2

V03AE01

ATC

polystyrene sulfonate; oral

4.3

7.2

WVA30, ,

SPAT

1.9

7.2

526

E000006, ,

ATC

1.8

7.2

103

585

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

7.2

114

668

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

7.3

7.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

7.2

282

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

30.2

7.2

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

30.2

7.2

M81.1

ICD-10 Finland

Postoophorectomy osteoporosis

30.2

7.2

9256

FHL

Synovectomy (knee 9311)

20.1

7.1

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

7.1

175

ZXD00

NOMESCO Finland

Emergency procedure

2.5

7.1

169

J01AA02

ATC

doxycycline; systemic

1.4

7.1

1074

9750

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.6

7.1

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

7.1

200

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

7.1

219

SPAT1291

SPAT

Other function in accordance with NCSP classification

3.1

7.1

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

7.1

131

803

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.1

7.0

291

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

7.0

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

4.2

7.0

A07EA06

ATC

budesonide; oral, local oral

2.2

7.0

259

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.7

6.9

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

5.5

6.9

137

Kela drug reimbursment

Uraemia requiring dialysis

7.6

6.9

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.8

6.9

125

WX704

NOMESCO Finland

Intubation

1.8

6.9

109

639

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.6

6.9

J01FA09

ATC

clarithromycin; systemic

1.4

6.9

402

3141

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.9

118

708

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.4

6.8

WX320

NOMESCO Finland

Spinalanesthesy

1.4

6.8

346

2637

R60.1

ICD-10 Finland

Generalized oedema

4.1

6.8

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.8

6.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

6.8

275

2013

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

5.7

6.8

E26.0

ICD-10 Finland

Primary hyperaldosteronism

40.2

6.8

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.1

6.8

M43.1

ICD-10 Finland

Spondylolisthesis

2.0

6.8

330

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.2

6.7

G72.9

ICD-10 Finland

Myopathy, unspecified

3.9

6.7

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.4

6.7

J45

ICD-10 Finland

Asthma

1.6

6.7

147

941

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

7.2

6.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

6.7

401

347

Kela drug reimbursment

denosumab

22.6

6.7

C739, ,

ICD-10 Finland

22.6

6.7

M80.1

ICD-10 Finland

Postoophorectomy osteoporosis with pathological fracture

22.6

6.7

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

3.7

6.6

S72.0

ICD-10 Finland

Fracture of neck of femur

2.0

6.6

339

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.1

6.6

9522

FHL

Synovectomy

7.8

6.6

SFA10

NOMESCO Finland

One-surface restoration

1.3

6.6

712

6102

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

12.3

6.6

R35

ICD-10 Finland

Polyuria

1.9

6.6

483

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

3.5

6.6

R5120

NOMESCO Finland

Preparation of an aid

2.3

6.6

220

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.3

6.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.2

6.6

L04AB06

ATC

golimumab; parenteral

4.2

6.6

L01CB

ATC

Podophyllotoxin derivatives

8.7

6.6

M70.2

ICD-10 Finland

Olecranon bursitis

2.5

6.6

164

S32.1

ICD-10 Finland

Fracture of sacrum

3.8

6.5

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

3.8

6.5

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

6.5

243

1748

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.1

6.5

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

6.5

175

1175

SPAT1097

SPAT

Recording of ECG

1.5

6.5

203

1409

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

2.3

6.5

221

49300

ICD-8 Finland

Asthma, bronchiale

2.6

6.5

135

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.1

6.5

E86

ICD-10 Finland

Volume depletion

2.5

6.5

165

A08

ICPC

Swelling

1.8

6.5

575

NHG20

NOMESCO Finland

Fusion of talocrural joint

5.7

6.5

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

5.7

6.5

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

3.2

6.5

BCA30

NOMESCO Finland

Unilateral adrenalectomy

70.2

6.4

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

70.2

6.4

K10.25

ICD-10 Finland

Sequences of jawbones

7.4

6.4

K92.1

ICD-10 Finland

Melaena

1.9

6.4

386

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

3.0

6.4

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.6

6.4

136

E28.3

ICD-10 Finland

Primary ovarian failure

14.4

6.4

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

14.4

6.4

9527

FHL

Alloarthroplasty, implant or endoprosthesis

14.4

6.4

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

6.4

330

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

6.4

365

XQ800

NOMESCO Finland

Prick test

1.8

6.4

555

XX9XE

NOMESCO Finland

Other ultrasound examination

3.8

6.4

ZY000

NOMESCO Finland

Hospital inpatient

3.8

6.4

R06.2

ICD-10 Finland

Wheezing

2.0

6.4

310

A10AB01

ATC

insulin (human); parenteral

2.4

6.4

185

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

6.3

423

K92.0

ICD-10 Finland

Haematemesis

2.7

6.3

125

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

6.3

339

2605

J05AB01

ATC

aciclovir; systemic

1.4

6.3

312

2364

L04AA24

ATC

abatacept; parenteral

6.0

6.3

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.0

6.3

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

11.1

6.3

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.1

6.3

R03BA02

ATC

budesonide; inhalant

1.5

6.3

244

1770

H01CB03

ATC

lanreotide; parenteral

18.1

6.3

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

+∞

6.3

M08.8

ICD-10 Finland

Other juvenile arthritis

+∞

6.3

H28.1*E20.9

ICD-10 Finland

Cataract in hypoparathyroidism

+∞

6.3

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

+∞

6.3

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.7

6.2

126

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.7

6.2

126

D01AE16

ATC

amorolfine; topical

1.6

6.2

162

1080

M03BX01

ATC

baclofen; systemic

2.8

6.2

109

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.6

6.2

132

R55

ICD-10 Finland

Syncope and collapse

1.6

6.2

155

1023

NFJ86

NOMESCO Finland

Late operation for fracture of femur to promote bone formation

26.8

6.2

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

26.8

6.2

V03AE03

ATC

lanthanum carbonate; oral

26.8

6.2

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.9

6.2

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

6.2

206

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

6.2

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

6.2

358

2785

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

6.2

433

3472

M01AX17

ATC

nimesulide; oral

1.4

6.2

338

2605

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.2

281

2098

NA2AA, ,

SPAT

4.0

6.2

Z00.0

ICD-10 Finland

General medical examination

1.4

6.2

255

1871

S01XA18

ATC

ciclosporin; ophthalmic

3.5

6.2

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

6.2

267

1976

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.3

6.2

1XC02, ,

NOMESCO Finland

5.4

6.2

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.4

6.2

RS220, ,

NOMESCO Finland

3.4

6.2

NF1DA

NOMESCO Finland

X-ray of hips

2.5

6.1

157

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

6.1

157

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

6.1

280

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

6.1

399

N18

ICPC

Paralysis/weakness

2.8

6.1

110

SPAT1125

SPAT

Stoma care and guidance

2.8

6.1

110

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

6.1

182

D72.1

ICD-10 Finland

Eosinophilia

7.7

6.1

E000001, ,

ATC

1.4

6.1

255

1874

E000003, ,

ATC

2.0

6.1

301

B01AB04

ATC

dalteparin; parenteral

1.9

6.1

371

A29

ICPC

General symptom/complaint other

1.5

6.1

194

1352

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.1

6.1

L74

ICPC

Fracture: hand/foot bone

2.4

6.1

164

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

2.9

6.1

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.8

6.1

459

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

8.6

6.1

L04AA17

ATC

[U] adalimumab

8.6

6.1

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

6.1

268

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

6.1

140

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

6.7

6.0

L13

ICPC

Hip symptom/complaint

1.4

6.0

307

2337

NDG79

NOMESCO Finland

Other excision, reconstruction or fusion of joint of II-V finger

10.1

6.0

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

10.1

6.0

N20.1

ICD-10 Finland

Calculus of ureter

2.4

6.0

177

R03BB01

ATC

ipratropium bromide; inhalant

2.1

6.0

255

NCU20

NOMESCO Finland

Removal of internal fixation device from elbow or forearm

3.5

6.0

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

6.0

152

1007

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003458) Phosphate [Moles/volume] in Serum or Plasma

731

1681

7.88

307.65

7.5

4.6

1.14

1.06

mmol/l

10.87

688

1544

(3010838) Calcium [Moles/time] in 24 hour Urine

349

161

28.38

307.65

3.3

1.7

4.52

4.35

mmol/24h

0.25

316

140

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

630

1060

9.86

307.65

5.3

2.9

55.95

76.85

ng/l

6.97

510

905

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

128

78.03

238.64

2.2

1.5

0.31

0.25

ug/l

0.51

107

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

147

21.74

193.14

7.5

7.1

7.61

265.00

ug/l

0.53

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1192

6386

6.30

171.09

6.1

2.4

85.81

79.56

nmol/l

13.61

1122

5705

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1253

7001

7.54

171.08

22.5

6.4

1.18

1.22

mmol/l

40.20

1108

6051

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1177

6330

5.94

165.48

18.7

5.8

1.18

1.21

mmol/l

34.18

1130

5808

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

156

123

14.12

163.92

7.1

5.3

75.81

44.92

u/ml

0.23

(3012095) Magnesium [Moles/volume] in Serum or Plasma

623

2223

4.20

150.79

5.7

3.1

0.79

0.82

mmol/l

7.71

590

2089

(3036481) Cortisol [Moles/volume] in Serum or Plasma

448

1256

4.74

149.62

2.7

1.9

317.10

390.16

nmol/l

5.23

420

1150

(3018418) pH of Serum or Plasma

905

4284

4.05

143.27

14.5

3.7

7.40

1.82

790

3041

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

351

847

5.17

140.10

5.6

3.4

4.34

4.48

pmol/l

1.57

326

745

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

50.96

117.60

2.5

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

927

5002

3.44

108.47

5.0

3.4

2.27

2.36

mmol/l

44.72

853

4519

(3004588) Protein electrophoresis panel - Serum or Plasma

331

960

4.19

102.18

2.3

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

364

1172

3.83

96.46

2.4

2.9

65.40

66.51

g/l

2.02

329

1068

(3012565) Volume of 24 hour Urine

19.03

86.80

3.2

2.2

1978.28

1832.81

0.33

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

325

1088

3.57

79.93

12.2

3.3

1.19

1.23

mmol/l

16.63

314

917

(3024561) Albumin [Mass/volume] in Serum or Plasma

976

6172

2.84

73.03

7.8

4.6

34.45

35.54

g/l

7.83

928

5786

(3034860) Kappa light chains.free [Mass/volume] in Serum

190

486

4.36

67.94

2.7

3.7

36.21

64.21

mg/l

1.23

141

428

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

189

488

4.31

66.72

2.7

3.7

29.55

55.04

mg/l

2.16

141

430

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

177

440

4.45

65.61

2.3

3.4

1.40

3.90

ratio

1.47

256

(40760888) Immunoglobulin light chains.free panel - Serum

139

304

4.96

60.21

2.9

4.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

277

999

3.20

59.06

4.8

2.9

9.52

10.54

g/l

3.02

260

918

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

7.53

58.07

1.4

1.1

123.25

110.25

pmol/l

0.38

119

(3006315) Basophils [#/volume] in Blood

985

6689

2.53

56.50

12.5

6.2

0.04

e9/l

0.43

910

5663

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

645

3634

2.42

56.44

3.3

2.4

3.53

2.90

mg/l

5.42

568

3120

(3013115) Eosinophils [#/volume] in Blood

1006

6912

2.55

56.03

12.8

6.4

0.18

0.19

e9/l

0.40

926

5943

(3001604) Monocytes [#/volume] in Blood

982

6682

2.51

55.70

12.4

6.2

0.61

0.58

e9/l

3.21

907

5659

(3022948) Iron [Moles/volume] in Serum or Plasma

467

2299

2.53

54.64

3.6

2.4

11.00

12.56

umol/l

5.44

436

2149

(42870588) Differential panel, method unspecified - Blood

744

4526

2.35

53.80

11.5

6.1

—

(3019198) Lymphocytes [#/volume] in Blood

989

6824

2.47

53.19

12.6

6.2

1.75

1.88

e9/l

2.28

925

5925

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

413

1961

2.56

51.74

3.6

2.3

19.37

21.91

3.66

386

1833

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1276

10094

3.53

50.50

16.6

8.1

77.49

80.10

u/l

0.80

1245

9521

(3019069) Monocytes/Leukocytes in Blood

914

6171

2.34

50.39

12.9

6.4

8.76

8.80

0.14

862

5756

(3004789) Transferrin [Mass/volume] in Serum or Plasma

434

2135

2.49

50.18

3.6

2.3

2.32

2.33

g/l

0.14

405

1976

(3006504) Eosinophils/Leukocytes in Blood

912

6159

2.34

50.15

12.6

6.3

2.67

2.78

0.68

860

5740

(3022096) Basophils/Leukocytes in Blood

909

6159

2.31

49.16

13.0

6.4

0.69

0.01

858

5730

(3032080) INR in Blood by Coagulation assay

910

6169

2.31

49.15

20.1

14.8

1.25

inr

0.00

780

5073

(3028026) IgM [Mass/volume] in Serum or Plasma

224

803

3.12

47.63

2.9

1.8

1.20

1.36

g/l

0.80

204

728

(3013650) Neutrophils [#/volume] in Blood by Automated count

1047

7609

2.42

46.94

15.6

9.6

4.57

4.07

e9/l

7.17

962

6558

(3002030) Lymphocytes/Leukocytes in Blood

909

6281

2.24

45.10

12.4

6.3

25.18

27.69

10.73

871

5931

(3018010) Neutrophils/Leukocytes in Blood

896

6166

2.22

44.76

12.2

6.3

60.21

57.33

10.97

861

5865

(3019309) Folate [Moles/volume] in Red Blood Cells

456

2412

2.31

43.78

1.9

1.7

1257.58

1182.47

nmol/l

0.74

349

1775

(3023368) Bacteria identified in Blood by Culture

613

3664

2.18

43.52

6.8

4.1

—

(3009343) pH of Capillary blood

217

817

2.95

42.06

5.8

3.7

7.42

1.29

189

669

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

221

841

2.93

42.01

5.9

3.7

5.28

5.19

kpa

0.79

213

814

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

441

2349

2.27

41.24

2.5

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

544

3155

2.17

41.16

1.5

1.3

0.81

1.53

u/ml

2.14

175

794

(3027945) Reticulocytes/Erythrocytes in Blood

334

1586

2.44

40.63

3.0

2.6

1.91

1.85

0.45

297

1413

(3009445) Proteinase 3 Ab [Units/volume] in Serum

165

543

3.31

40.20

1.9

1.4

15.46

15.90

iu/ml

—

(3002179) Metamyelocytes/Leukocytes in Blood

264

1131

2.64

39.85

6.2

4.1

0.78

0.65

0.57

104

314

(3044927) Protein electrophoresis panel - Urine

140

5.68

39.72

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

194

708

3.01

39.65

5.2

3.7

2.62

1.87

mmol/l

1.84

158

528

(3009214) Lutropin [Units/volume] in Serum or Plasma

206

4.76

39.44

1.5

1.3

14.49

11.89

u/l

0.58

160

(3012501) Base excess in Blood by calculation

100

236

4.48

39.22

4.8

3.7

3.13

2.88

mmol/l

0.31

164

(3019225) pH of Specimen

290

1321

2.50

38.41

12.3

3.8

7.38

7.35

3.34

249

908

(3023520) Reticulocytes [#/volume] in Blood

277

1235

2.54

38.40

3.3

2.6

73.54

71.28

e9/l

0.45

216

898

(3013826) Glucose [Moles/volume] in Serum or Plasma

1029

7712

2.20

38.38

8.1

4.7

6.53

6.68

mmol/l

1.85

1002

7305

(3017181) Myelocytes/Leukocytes in Blood

269

1183

2.57

38.38

6.2

4.3

0.98

0.96

0.06

105

334

(3011985) Renin [Units/volume] in Plasma

171

5.09

38.33

3.8

1.2

67.27

90.28

mu/l

0.25

151

(3007853) Bacteria identified in Skin by Aerobe culture

316

1500

2.42

38.24

2.7

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

319

1524

2.41

38.03

4.8

4.5

249.03

248.96

u/l

0.00

291

1436

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

601

3.12

37.85

1.7

2.3

3.64

3.76

g/l

0.49

152

548

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

669

4293

2.05

37.84

2.8

2.2

158.71

204.94

u/l

1.07

631

4056

(3003181) Sodium [Moles/volume] in Urine

112

296

4.02

37.82

1.6

1.4

63.45

58.43

mmol/l

0.58

243

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

602

3.11

37.74

1.8

2.3

7.45

7.55

g/l

0.29

151

548

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

602

3.11

37.74

1.7

2.3

4.30

4.27

g/l

0.12

152

548

(3042936) Bacteria identified in Isolate by Culture

368

1877

2.30

37.69

3.4

1.9

—

(3025159) Blasts/Leukocytes in Blood

261

1148

2.56

37.13

6.7

4.6

0.08

0.02

263

(1616796) Gas panel - Central venous blood

102

256

4.21

36.92

4.5

3.4

—

(3021440) Promyelocytes/Leukocytes in Blood

259

1138

2.56

36.91

6.4

4.3

0.12

0.04

286

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

570

3.12

36.38

1.8

2.4

2.86

3.02

g/l

1.23

144

516

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

157

538

3.16

35.65

2.1

2.4

0.33

1.08

g/l

2.24

120

465

(3026782) Osmolality of Urine

456

2591

2.12

35.30

4.5

2.9

469.06

508.80

mosm/kgh2o

3.93

401

2266

(3011412) CD3 cells [#/volume] in Blood

116

5.82

35.10

1.7

1.9

1035.34

1197.52

e6/l

0.75

(3020779) Urea [Moles/volume] in Serum or Plasma

253

1129

2.51

34.75

11.1

5.7

10.75

9.51

mmol/l

1.28

244

1077

(3007164) IgA [Mass/volume] in Serum or Plasma

470

2715

2.09

34.72

2.3

1.5

2.33

2.39

g/l

0.24

307

1563

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

141

460

3.29

34.71

1.4

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1241

10249

2.63

34.08

10.0

4.7

16.45

14.91

pmol/l

60.09

1162

9363

(3000850) Epithelial cells [#/volume] in Urine

506

3022

2.05

34.00

4.1

2.7

5.21

6.99

e6/l

3.09

467

2747

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.51

33.94

1.9

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

602

2.97

33.54

2.4

1.8

1.49

1.51

g/l

0.06

141

528

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

501

2997

2.04

33.39

4.6

2.8

2.41

2.46

mmol/l

8.32

450

2702

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

122

377

3.45

32.71

4.2

3.7

1.70

1.47

mg/l

1.74

113

339

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

233

1028

2.51

32.66

2.4

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

469

2771

2.03

32.11

9.0

4.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

277

1333

2.34

31.98

3.0

2.1

0.20

0.21

g/l

0.94

259

1246

(3037522) Nuclear Ab [Titer] in Serum

348

1857

2.16

31.15

1.7

1.3

516.29

565.25

titre

0.22

434

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

135

459

3.14

30.96

1.5

2.3

0.01

0.00

g/l

0.32

108

417

(3035715) Granulocytes [#/volume] in Blood

227

4.07

30.66

4.1

3.1

4.40

4.21

e9/l

0.34

227

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

124

403

3.27

30.65

2.7

1.7

0.23

g/l

0.22

116

385

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1186

9735

2.30

30.62

10.0

4.6

16.09

13.16

mm/h

8.68

1120

9072

(3001122) Ferritin [Mass/volume] in Serum or Plasma

840

6115

1.91

30.33

4.5

3.0

124.23

108.83

ug/l

0.62

775

5658

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

274

1343

2.29

30.16

5.0

3.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

940

7128

1.94

29.65

8.9

6.3

10.36

11.27

umol/l

1.12

900

6779

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

332

1776

2.13

29.33

2.3

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

844

6195

1.89

29.24

3.8

2.7

—

estimate

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

130

447

3.10

29.22

1.4

2.3

0.00

g/l

-0.00

397

(3037756) Immunofixation for Serum or Plasma

104

313

3.51

29.00

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

144

528

2.92

28.90

1.6

2.3

9.30

10.36

g/l

1.96

120

470

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

144

530

2.91

28.70

2.3

1.9

2.46

1.84

ug/l

0.30

124

466

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

144

530

2.91

28.70

2.4

2.0

38.88

40.33

u/l

0.30

122

466

(3019977) pH of Arterial blood

297

1540

2.17

28.32

8.5

7.1

7.42

0.07

165

828

(3027801) Oxygen [Partial pressure] in Arterial blood

297

1541

2.17

28.27

8.4

7.1

11.68

12.30

kpa

1.45

286

1482

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

297

1541

2.17

28.27

8.4

7.1

5.18

5.10

kpa

0.51

287

1483

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

123

420

3.11

27.96

2.6

1.7

1.20

1.21

g/l

0.12

116

401

(3016502) Oxygen saturation in Arterial blood

271

1364

2.22

27.79

8.4

7.4

95.20

95.62

0.54

261

1320

(3003396) Base excess in Arterial blood by calculation

293

1528

2.16

27.46

8.3

7.1

1.73

1.04

mmol/l

1.75

254

1270

(4062490) Immunoglobulin typing, IgG

115

5.12

26.93

2.6

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

104

330

3.32

26.68

2.5

2.2

12.28

12.51

mg/l

0.08

308

(3035933) Granulocytes/Leukocytes in Blood

285

3.50

26.61

4.2

2.9

61.98

58.40

1.89

285

(3028192) IgG subclass 2 [Mass/volume] in Serum

117

5.03

26.41

2.4

1.4

2.59

2.93

g/l

0.56

(3027135) IgG subclass 1 [Mass/volume] in Serum

117

5.03

26.41

2.4

1.4

6.45

7.14

g/l

0.57

(3024139) IgG subclass 3 [Mass/volume] in Serum

117

5.03

26.41

2.4

1.4

0.37

0.39

g/l

0.13

(3044640) Blood type and Crossmatch panel - Blood

636

4369

1.82

26.26

3.5

2.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

148

583

2.72

25.89

2.6

1.9

10.12

7.92

iu/ml

0.40

133

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

619

4255

1.80

25.20

3.9

2.5

60.65

80.89

u/l

0.52

577

3918

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

713

5121

1.79

24.92

5.8

3.9

33.56

50.81

ng/l

0.72

595

3715

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

629

4357

1.79

24.85

4.3

3.2

1266.80

1236.81

ng/l

0.09

552

3743

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

5.85

24.70

1.7

2.2

235.97

200.54

e6/l

0.50

(3024980) IgG subclass 4 [Mass/volume] in Serum

188

3.98

24.66

2.3

1.7

0.63

0.78

g/l

0.40

152

(3002582) Erythrocytes [#/volume] in Urine

626

4343

1.79

24.50

5.2

3.4

18.70

65.25

e6/l

2.33

535

3286

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

231

3.66

24.47

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

114

403

2.99

24.36

1.7

1.5

0.07

0.06

iu/ml

0.04

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

214

3.75

24.16

7.0

4.5

940.06

377.00

iu/ml

0.70

(3015171) Extractable nuclear Ab [Units/volume] in Serum

134

521

2.74

24.01

1.4

1.2

0.30

1.13

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

5.63

23.76

1.6

2.0

375.50

474.98

e6/l

0.85

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

103

349

3.10

23.68

2.7

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

307

3.24

23.64

2.8

1.3

348.73

290.89

mu/l

0.85

273

(3030467) Casts [#/volume] in Urine by Automated count

557

3769

1.78

23.46

4.9

3.3

0.28

0.46

e6/l

1.96

470

2749

(3021601) Nitrite [Presence] in Urine by Test strip

905

7037

1.78

23.44

6.3

4.3

0.00

estimate

0.50

261

1455

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

234

3.56

23.28

1.5

1.3

662.86

347.62

titre

—

(3037121) Protein [Mass/volume] in Urine

122

459

2.81

23.26

2.7

3.1

377.40

463.18

mg/l

0.16

173

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

300

1675

2.00

23.01

2.3

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

916

7187

1.77

22.58

6.2

4.4

0.00

0.22

estimate

0.54

253

1420

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

134

4.39

22.43

1.3

1.2

69.73

54.88

u/l

0.72

121

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

3.53

22.42

1.5

1.4

—

(3023419) Bacteria identified in Sputum by Culture

183

3.85

22.34

3.1

2.4

—

(3022313) Gas panel - Capillary blood

142

590

2.56

22.25

6.3

3.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1071

8820

1.86

22.23

7.8

5.3

3175.23

2699.32

e6/l

0.11

122

(3009508) Creatinine [Moles/volume] in Urine

649

4647

1.73

22.00

3.9

3.3

6.20

6.75

mmol/l

2.75

572

3897

(3008295) Osmolality of Serum or Plasma

149

4.16

21.99

1.5

1.2

273.46

273.76

mosm/kgh2o

0.03

108

(3035350) Ketones [Presence] in Urine by Test strip

906

7115

1.75

21.95

6.2

4.3

0.00

3.26

estimate

1.07

268

1508

(3021589) Normoblasts [#/volume] in Blood

773

5818

1.72

21.76

24.9

11.5

0.00

e9/l

0.45

688

4720

(3021447) Carbon dioxide [Partial pressure] in Venous blood

256

1382

2.04

21.44

6.4

3.4

6.07

5.79

kpa

2.89

250

1340

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

404

2.84

21.35

2.2

2.0

5.93

18.98

iu/l

0.42

157

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

328

3.03

21.14

1.8

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

145

4.13

21.08

2.3

1.5

60.81

59.83

0.06

(3002173) Hemoglobin [Mass/volume] in Arterial blood

242

1290

2.06

20.95

9.3

7.5

117.44

119.17

g/l

0.67

237

1261

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

221

3.48

20.86

1.7

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

278

3.19

20.73

1.6

1.4

—

(3000991) Gas panel - Venous blood

226

1183

2.08

20.52

11.9

7.6

—

(3029937) Albumin [Presence] in Urine by Test strip

565

3952

1.71

20.42

6.8

4.5

0.00

estimate

1.23

255

1368

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

162

3.89

20.42

1.7

1.1

2000.94

288.13

pmol/l

0.50

141

(40761536) Microorganisms panel - Urine sediment

202

1015

2.15

20.40

6.3

4.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

176

3.76

20.39

3.5

2.8

322.50

2194.38

u/ml

—

(3012544) pH of Venous blood

251

1373

2.01

20.17

6.3

3.4

7.38

0.41

152

752

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

343

2.93

20.10

1.7

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

585

4152

1.69

19.89

2.1

1.7

21.72

21.05

nmol/l

0.17

506

3439

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

115

458

2.64

19.61

6.1

4.2

25.41

24.88

mmol/l

1.04

107

424

(3018095) Leukocytes [#/volume] in Urine

674

4997

1.66

19.18

6.3

4.1

103.67

112.86

e6/l

0.09

551

3447

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

491

3353

1.71

19.08

3.4

2.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

330

2013

1.83

18.96

2.8

2.1

29.30

29.25

0.05

325

1953

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

181

3.60

18.84

1.5

—

(3002032) Base excess in Venous blood by calculation

241

1331

1.98

18.75

6.6

3.4

2.56

1.88

mmol/l

2.02

223

1154

(3002079) Sodium [Moles/time] in 24 hour Urine

7.12

18.69

1.4

1.3

176.07

149.34

mmol/24h

0.64

(3045424) Erythrocytes [Presence] in Urine

150

693

2.30

18.54

2.6

2.2

0.00

estimate

0.50

216

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

111

447

2.61

18.50

1.4

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

106

419

2.65

18.34

1.5

2.3

0.00

g/l

-0.00

396

(40768797) Stomach Pathology biopsy report

316

1922

1.83

18.25

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

286

1688

1.87

18.18

3.7

3.1

6.13

4.56

e9/l

0.69

233

1448

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

115

476

2.54

18.11

2.9

2.2

378.03

822.57

ug/l

0.48

109

447

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

162

3.69

18.08

13.8

6.1

13.60

12.39

mg/l

0.80

153

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

232

3.22

18.01

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

152

3.72

17.42

1.8

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

7.47

17.41

1.5

2.0

0.24

0.29

e9/l

0.20

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

384

2.64

16.73

2.0

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1308

11838

2.28

16.69

11.6

5.9

1.95

1.94

mu/l

0.03

1241

10906

(3000494) Fungus identified in Specimen by Culture

270

1606

1.84

16.61

2.2

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

791

6241

1.60

16.53

2.7

2.2

99.18

97.08

pmol/l

0.55

424

3053

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

330

2.74

16.31

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

284

2.85

15.79

1.9

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

419

2873

1.65

15.38

1.9

1.8

13714753.35

21901974.86

pmol/l

0.21

350

2356

(3015736) pH of Urine

727

5687

1.57

15.27

5.1

3.8

6.47

6.27

4.25

384

3113

(3017143) Hepatitis C virus Ab [Presence] in Serum

218

1252

1.88

14.88

1.7

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

325

2.65

14.64

2.7

2.1

121.71

126.79

g/l

1.01

260

(3041096) Erythrocytes [Presence] in Urine by Automated

507

3682

1.59

14.52

5.4

3.7

0.00

0.04

estimate

1.02

229

1152

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

158

3.38

14.32

1.7

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

458

3259

1.60

14.25

3.4

2.7

333.77

331.87

umol/l

0.14

397

2830

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

427

2989

1.61

14.22

2.8

1.8

1.51

1.32

mg/l

0.43

338

2319

(3004809) Band form neutrophils/Leukocytes in Blood

196

3.10

14.06

3.4

3.2

0.99

1.76

1.56

172

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

266

1656

1.75

13.83

1.7

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.48

13.59

1.3

1.2

23.56

14.68

u/l

0.92

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

390

2.42

13.31

8.4

3.2

0.39

0.38

iu/ml

0.10

222

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

4.36

13.16

1.3

1.2

91.89

70.96

u/l

0.51

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

400

2.39

13.04

1.4

1.3

11.63

9.11

u/ml

0.14

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

400

2.39

13.04

1.3

5.70

2.66

u/ml

0.57

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

323

2.53

12.78

1.3

18.70

5.29

u/ml

—

(3000012) Reticulocyte production index

183

3.03

12.46

4.4

2.3

1.05

0.91

0.79

115

(3033658) Prothrombin time (PT) actual/Normal

462

3376

1.55

12.46

5.9

4.0

91.39

90.44

0.35

453

3303

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.15

12.34

1.7

1.5

3.78

6.48

u/l

0.69

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

436

2.29

12.32

3.1

2.7

—

(3022145) Colonoscopy Study observation

248

1565

1.71

12.17

1.5

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

661

5236

1.49

12.01

6.5

4.3

0.02

0.08

estimate

1.18

225

1172

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

4.73

11.91

1.5

1.6

4.10

1.86

nmol/l

0.73

(3008152) Bicarbonate [Moles/volume] in Arterial blood

148

804

1.94

11.87

7.4

6.4

25.75

24.47

mmol/l

3.30

141

769

(3017446) Testosterone [Moles/volume] in Serum or Plasma

102

483

2.20

11.85

3.2

2.1

11.88

12.82

nmol/l

0.50

433

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

375

2.35

11.67

1.4

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

139

744

1.96

11.64

10.3

9.0

15.54

15.63

0.14

134

718

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

421

2.27

11.61

1.3

30.71

33.46

u/ml

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

116

584

2.07

11.52

5.5

4.6

1.48

1.51

0.13

108

552

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

176

1024

1.82

11.40

3.7

2.6

63.12

65.42

ml/min/173m2

0.32

105

447

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

105

3.59

11.34

2.2

1.5

—

(40768804) Tissue Pathology biopsy report

672

5392

1.47

11.16

2.3

2.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

5.07

11.01

1.9

1.6

27.74

29.59

0.24

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

150

3.07

10.71

1.4

1.2

—

nmol/l

—

(3025941) Bacteria identified in Stool by Culture

126

671

1.96

10.71

1.5

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1325

12364

2.02

10.64

36.3

16.4

22.53

23.65

mg/l

0.72

1223

10206

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

190

2.80

10.53

1.4

1.2

0.52

0.45

nmol/l

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

446

2.16

10.48

1.8

1.4

258.86

289.67

ug/g

0.89

260

(3048689) Calprotectin [Mass/mass] in Stool

264

1758

1.62

10.40

3.3

2.3

161.46

118.69

ug/g

1.47

201

1391

(3019550) Sodium [Moles/volume] in Serum or Plasma

1351

12713

2.21

10.34

40.1

19.5

139.30

139.63

mmol/l

3.51

1341

12473

(3042631) Mycobacterium sp identified in Specimen

171

2.87

10.19

2.2

2.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.57

10.08

1.7

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

161

2.92

10.08

1.2

0.19

0.18

nmol/l

0.07

130

(3023103) Potassium [Moles/volume] in Serum or Plasma

1351

12730

2.18

10.02

40.4

19.7

3.93

3.96

mmol/l

5.75

1338

12467

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1288

11946

1.81

10.00

33.3

16.3

76.12

77.97

ml/min/173m2

2.09

1240

11084

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

3.18

9.93

3.6

3.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

363

2.25

9.90

2.4

1.6

15574.20

12063.40

e6/l

0.24

256

(3026389) Candida sp identified in Specimen by Organism specific culture

180

2.78

9.84

2.3

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

933

8072

1.45

9.80

4.8

3.2

55.08

47.16

u/l

1.38

856

7505

(3017704) Immunofixation for Urine

3.82

9.79

1.6

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.72

9.73

1.9

1.4

4.54

6.79

u/l

1.56

(3021879) Hepatitis B virus core Ab [Presence] in Serum

144

827

1.82

9.71

1.5

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.43

9.71

3.1

1.7

0.60

0.62

mmol/l

0.33

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.06

9.53

1.6

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

501

2.03

9.35

2.6

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

334

2410

1.50

9.10

1.4

1.3

29.79

11.56

u/ml

2.44

121

886

(43055514) Macroprolactin [Presence] in Serum or Plasma

18.73

8.94

1.2

1.0

—

(3044941) Cell count panel - Synovial fluid

256

2.40

8.93

2.0

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

461

2.04

8.91

2.5

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

352

2577

1.49

8.91

1.4

1.3

46.54

35.54

iu/ml

0.65

121

811

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.64

8.86

2.4

2.9

44.10

40.33

0.54

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.92

8.85

1.5

1.3

155.95

66.21

nmol/24h

1.22

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.82

8.80

1.6

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

149

890

1.75

8.80

1.9

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

259

2.37

8.71

2.5

2.9

33.09

34.55

umol/l

0.17

230

(3017569) Oxygen content in Arterial blood

3.76

8.63

1.7

2.9

15.99

16.66

0.50

(3005322) IgE [Units/volume] in Serum or Plasma

146

873

1.75

8.59

1.6

1.3

176.80

211.70

u/ml

0.26

131

804

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.65

8.58

3.0

1.2

402.95

308.29

mu/l

1.06

(3007930) Methemoglobin/Hemoglobin.total in Blood

525

1.95

8.54

5.8

4.9

0.85

0.89

0.30

493

(36660697) Celiac disease serology panel - Serum

178

1132

1.65

8.34

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

108

3.10

8.16

1.3

1.1

—

titre

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

267

2.30

8.15

1.9

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

171

1091

1.64

7.91

3.3

2.3

0.30

0.60

e6/l

1.39

160

1036

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.34

7.81

1.5

58.67

86.68

ng/l

2.13

(3003329) Lymphocytes/Leukocytes in Synovial fluid

101

3.12

7.73

2.7

1.5

27.16

32.55

0.37

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.47

7.69

1.6

1.4

—

(3045414) Leukocytes [Presence] in Urine

207

1399

1.56

7.53

2.5

2.2

0.00

0.02

estimate

0.78

276

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

317

2.13

7.47

1.3

1.2

46.04

51.04

u/ml

0.11

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

121

714

1.76

7.46

1.8

1.5

—

(3004451) EKG impression Narrative

3.47

7.41

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

154

2.64

7.41

4.0

3.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

262

1873

1.49

7.32

1.9

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.19

7.28

1.5

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

136

835

1.70

7.28

6.5

3.0

123.21

127.66

g/l

1.96

131

805

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

105

3.00

7.26

1.1

1.3

1.01

2.30

u/ml

0.50

(40758558) Short blood count panel - Blood

511

4126

1.37

7.21

10.2

6.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

2.83

7.19

1.5

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

2.83

7.19

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

2.83

7.19

2.4

2.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

2.83

7.19

1.5

1.4

—

(40768443) Skin Pathology biopsy report

109

631

1.79

7.18

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.15

7.16

1.6

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

169

2.53

7.13

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

169

2.53

7.13

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

169

2.53

7.13

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

169

2.53

7.13

1.8

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.40

6.97

1.4

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

355

2.02

6.89

1.3

1.1

160.00

86.67

titre

—

(3034891) Synovial lining cells/cells in Synovial fluid

3.81

6.82

2.6

1.3

2.00

2.18

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

168

2.48

6.72

2.2

2.4

34.88

25.81

mg/l

0.43

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

315

2369

1.42

6.70

4.0

2.9

1.20

1.30

e6/l

0.22

197

1210

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.95

6.45

1.5

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.76

6.37

3.7

4.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

501

1.81

6.15

1.4

1.3

29.92

29.20

iu/l

0.06

428

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

221

2.21

6.09

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

228

2.19

6.06

1.3

1.2

21.59

21.20

u/l

0.02

192

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

164

1105

1.55

6.03

2.5

2.4

7.99

6.57

ug/l

0.35

133

957

(3014271) Vancomycin [Susceptibility]

3.37

6.01

3.4

2.7

—

(3042733) HLA Ab [Presence] in Serum

7.28

5.93

5.7

3.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.03

5.90

1.5

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

103

622

1.71

5.89

1.1

1.2

—

180.73

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

107

2.75

5.87

2.4

2.6

27.25

39.24

iu/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

139

2.48

5.64

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

183

2.28

5.61

1.7

1.2

2.25

3.26

u/ml

0.31

(3044242) Glucose [Moles/volume] in Arterial blood

2.96

5.58

1.5

2.7

7.08

9.17

mmol/l

1.99

(3020682) Albumin/Creatinine [Ratio] in Urine

540

4528

1.31

5.54

4.6

4.0

9.21

7.48

mg/mmol

0.39

340

2652

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

216

1571

1.44

5.45

11.4

6.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

239

2.09

5.41

1.3

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

516

4313

1.31

5.38

4.3

3.0

32.46

32.37

u/l

0.01

485

4061

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

115

733

1.62

5.36

6.8

2.8

1.18

1.13

0.28

115

726

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

927

10104

0.76

5.34

42.4

21.9

329.03

330.98

g/l

7.82

921

10043

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

181

2.24

5.32

1.7

1.2

6.33

3.47

u/ml

0.52

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

113

2.60

5.32

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

283

1.98

5.26

3.7

3.5

76.40

1346.53

u/ml

0.79

263

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

195

2.19

5.26

1.3

135.91

163.54

au/ml

0.95

(3048879) Bone marrow aspiration report

5.43

5.23

1.2

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

170

2.27

5.20

1.7

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

115

2.55

5.14

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

115

2.55

5.14

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

121

2.51

5.14

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

152

2.34

5.12

1.7

1.4

0.34

0.36

nmol/l

0.09

123

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.87

5.10

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.87

5.10

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.36

5.08

4.9

2.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1356

13082

1.75

5.02

46.0

21.7

80.39

73.79

umol/l

5.57

1350

12930

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

819

7311

1.28

5.00

3.3

2.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

159

1109

1.49

4.97

4.7

3.0

166.46

201.88

ng/l

1.01

148

1020

(40759836) Histone Ab [Presence] in Serum by Immunoblot

117

2.51

4.97

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

6.92

4.95

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

6.92

4.95

1.3

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

6.92

4.95

1.3

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

112

725

1.59

4.92

6.9

2.8

0.63

0.61

0.34

112

719

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

137

2.37

4.85

1.1

1.0

—

(3012516) Albumin [Mass/volume] in Urine

524

4436

1.29

4.84

3.8

3.4

39.19

36.67

mg/l

0.14

331

2680

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1347

12984

1.68

4.84

22.8

12.6

23.25

24.33

u/l

1.91

1317

12595

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.01

4.84

1.6

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.01

4.84

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.01

4.84

1.6

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.01

4.84

1.6

1.4

—

(4035726) Immunohistochemistry procedure

170

1210

1.46

4.80

1.6

1.4

—

(3036489) Thrombin time

501

1.70

4.80

3.2

2.2

21.70

21.11

0.26

451

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

6.51

4.77

5.4

2.2

—

(21494434) Karyotype in Bone marrow

120

2.45

4.73

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

133

2.36

4.68

2.0

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

392

1.77

4.63

5.5

2.6

3.60

3.57

g/l

0.05

377

(3047181) Lactate [Moles/volume] in Blood

370

1.79

4.61

6.4

5.8

1.18

1.29

mmol/l

0.56

330

(3052851) Hemolysis interference index of Serum or Plasma

378

1.78

4.59

4.0

3.3

2.59

2.42

index

0.04

180

(40763480) Human metapneumovirus Ag [Presence] in Specimen

14.06

4.58

1.4

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

1544

1.40

4.52

3.3

2.5

10.07

7.24

umol/l

0.54

177

1347

(3045142) Bone marrow Pathology biopsy report

168

2.17

4.49

1.1

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.43

4.47

1.4

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.41

4.44

1.2

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

131

2.32

4.38

1.8

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

335

2713

1.31

4.25

5.1

4.0

408.87

315.06

ng/l

0.15

276

2162

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.06

4.24

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.06

4.24

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1237

11767

1.39

4.22

7.9

6.6

39.98

39.41

mmol/mol

1.33

1140

10940

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

442

1.69

4.20

1.5

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

134

2.27

4.17

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

147

2.20

4.17

1.7

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

110

2.39

4.08

1.2

1.1

—

(3016750) Collection duration of Urine

2.88

4.07

2.9

2.1

501.83

494.94

min

0.08

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

2.37

4.01

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1050

0.60

3.97

2.0

3.23

3.36

ratio

0.48

834

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

2.55

3.97

1.3

1.2

11.64

11.18

u/l

0.07

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.04

3.97

1.1

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

144

2.18

3.94

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.58

3.89

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

119

2.29

3.88

1.3

1.2

49.20

53.71

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

324

1.76

3.81

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

385

1.69

3.80

3.9

2.6

230.60

189.77

2.07

371

(3039000) Anion gap in Blood by calculation

258

1.85

3.80

7.1

6.6

10.77

11.03

mmol/l

0.19

232

(3018572) Chloride [Moles/volume] in Blood

258

1.85

3.80

7.1

6.6

104.20

105.25

mmol/l

0.76

232

(3000093) Morphology [Interpretation] in Blood Narrative

121

2.26

3.75

1.3

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.59

3.72

1.7

1.6

11.91

12.36

umol/l

0.15

(3004775) Volume in Urine collected for unspecified duration

2.52

3.72

2.9

2.3

720.93

592.32

0.66

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

270

2160

1.31

3.72

4.7

3.0

2.98

3.44

e6/l

0.32

152

1000

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

276

1.80

3.66

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

276

1.80

3.66

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

198

1.94

3.60

1.4

1.3

328.78

246.57

u/ml

0.93

105

(21494755) Public health laboratory ask at order entry panel

840

0.58

3.58

1.3

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.96

3.58

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.96

3.58

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

235

1.86

3.54

1.3

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

131

2.16

3.53

1.5

1.4

549266.33

170103.24

e6/l

0.63

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.90

3.47

1.5

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.57

3.43

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

336

1.69

3.39

1.5

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

140

2.09

3.39

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.02

3.37

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.66

3.29

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.95

3.29

1.3

1.0

—

(3028433) Virus identified in Specimen by Culture

3.04

3.25

1.3

1.2

—

(3024932) HLA-DR beta [Type]

4.19

3.19

1.0

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

2.33

3.18

1.4

1.2

391.25

105.00

titre

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

151

2.01

3.16

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.52

3.11

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

128

940

1.40

3.10

1.3

1.2

126.43

144.08

u/ml

0.22

353

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

210

1664

1.31

3.09

5.5

5.1

34.62

33.40

0.72

142

1051

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.69

3.09

1.1

1.2

—

(3024471) HLA-A [Type]

4.02

3.08

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

211

1.82

3.02

1.2

53.98

122.90

iu/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

10.03

2.98

1.6

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

10.03

2.98

1.2

186.20

387.40

umol/24h

—

(3023199) Leukocytes [#/volume] in Pleural fluid

148

1.98

2.96

1.5

1.3

12497.33

1716.17

e6/l

0.44

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

114

2.12

2.95

1.3

1.2

—

(3000492) Spirometry study

155

1186

1.34

2.92

2.1

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

259

1.72

2.89

1.1

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.11

2.88

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

136

2.00

2.86

1.8

1.3

35.59

30.03

u/l

0.29

111

(3020876) Protein [Mass/time] in 24 hour Urine

143

1.98

2.86

3.0

2.1

0.45

1.00

g/24h

1.76

(3028308) Erythrocytes [#/volume] in Pleural fluid

130

2.02

2.81

1.5

1.4

47168.83

35069.24

e6/l

0.16

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.41

2.80

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

263

1.69

2.75

3.5

2.2

99.77

94.29

ug/min

0.04

155

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

389

1.57

2.73

1.4

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.38

2.73

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.52

2.70

2.1

1.7

38.17

40.12

g/l

0.64

(3050794) Legionella sp Ab [Presence] in Serum

6.02

2.70

1.2

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

281

1.66

2.66

1.3

1.5

30.24

40.05

e6/l

0.13

206

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.81

2.65

1.6

1.2

115.00

108.41

0.58

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.40

2.63

2.0

2.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

134

1020

1.35

2.63

1.7

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

393

1.55

2.62

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

127

1.99

2.61

1.2

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

283

1.65

2.60

1.3

1.6

535.82

230.92

e6/l

0.30

220

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.16

2.55

25.0

13.0

4.48

5.34

mmol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

102

748

1.39

2.53

2.5

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

397

1.53

2.52

1.4

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.99

2.49

3.7

3.0

5.55

4.84

kpa

0.99

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.99

2.49

3.7

3.0

11.37

9.98

kpa

0.98

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.39

2.47

2.1

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

256

1.66

2.47

1.5

—

(3002256) Pathology report gross observation

211

1724

1.26

2.46

1.3

—

(40768446) Kidney Pathology biopsy report

3.14

2.43

1.9

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.04

2.36

1.4

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.27

2.34

1.1

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

784

0.66

2.28

1.7

1.8

3.38

3.48

mmol/l

0.31

562

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.76

2.27

1.7

1.3

—

(3019174) dRVVT (LA screen)

4.63

2.27

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

156

1.81

2.26

1.4

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

3.90

2.25

1.4

1.3

67.43

63.83

ug/l

—

(3045788) Cell count panel - Pleural fluid

128

1.89

2.22

1.5

1.3

—

(3007461) Platelets [#/volume] in Blood

1359

13322

1.43

2.19

52.4

25.4

265.89

254.94

e9/l

6.52

1349

13056

(3003327) Ova and parasites identified in Stool by Light microscopy

461

1.45

2.17

1.9

1.7

—

(40768806) Pleura Pathology biopsy report

122

1.90

2.16

1.4

1.7

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1359

13324

1.43

2.16

52.1

25.3

91.56

91.29

1.23

1353

13183

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

181

1.73

2.16

1.6

1.3

—

(3035941) MCH [Entitic mass]

1359

13326

1.43

2.14

52.0

25.2

30.13

30.27

1.98

1353

13185

(3026361) Erythrocytes [#/volume] in Blood

1359

13326

1.43

2.14

52.2

25.3

4.29

4.41

e12/l

14.71

1348

13009

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1359

13326

1.43

2.14

53.2

25.8

38.87

39.64

8.01

1353

13181

(3010813) Leukocytes [#/volume] in Blood

1359

13327

1.43

2.13

52.4

25.4

7.13

6.68

e9/l

10.94

1348

13009

(40768441) Liver Pathology biopsy report

2.06

2.11

1.9

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

1359

13329

1.42

2.10

52.8

25.5

128.11

132.36

g/l

23.18

1353

13192

(40757494) Bilirubin.total [Moles/volume] in Blood

2.27

2.08

1.7

2.7

—

28.12

—

(44806071) Cardiolipin IgM antibody measurement

4.01

2.04

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

4.01

2.04

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

177

1.71

2.03

1.6

1.3

—

(3012441) Differential panel - Pleural fluid

125

1.85

2.03

1.3

1.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.09

2.01

1.5

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

1.72

2.01

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

1.71

1.97

1.6

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.99

1.95

1.1

1.2

—

(4015189) Microbial culture of sputum

2.97

1.93

3.3

3.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.46

1.93

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

180

1.68

1.92

1.6

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

106

1.90

1.91

1.2

1.4

—

51.43

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.25

1.91

1.5

1.1

0.47

0.49

ratio

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

173

1.69

1.90

1.6

1.3

—

(3016879) Cocaine [Presence] in Urine

308

1.51

1.89

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

3.19

1.88

2.7

1.1

14.29

16.76

umol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

350

1.47

1.87

1.3

—

(3034426) Prothrombin time (PT)

2.66

1.86

1.2

1.4

30.11

28.53

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.09

1.86

1.3

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.21

1.84

1.2

1.3

153.08

143.15

nmol/l

0.17

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

327

0.54

1.83

1.1

1.2

1.52

1.59

g/l

0.44

327

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.05

1.80

1.0

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

177

1.65

1.77

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

314

1.48

1.75

1.8

2.1

8263.81

4646.65

u/l

—

137

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1.94

1.75

1.1

1.3

1.74

2.01

mmol/l

1.52

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.23

1.74

1.1

764.33

177.97

iu/ml

0.64

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.86

1.71

4.4

5.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.07

1.70

1.3

1.0

1.20

1.24

u/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.01

1.70

2.1

1.5

79.40

79.04

umol/l

0.02

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

113

900

1.28

1.68

2.8

2.5

48.89

19.72

au/ml

1.41

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.51

1.66

2.8

1.3

11.20

8.74

ug/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.17

1.66

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.59

1.66

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

1.90

1.65

1.0

315.88

289.58

mg/l

0.95

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

301

0.56

1.61

1.1

0.59

0.65

ratio

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

182

1.61

1.1

—

(4195642) Thrombophilia screening test

159

1.65

1.59

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1066

10261

1.15

1.58

41.1

20.7

14.21

13.69

21.95

1060

10122

(3020650) Glucose [Presence] in Urine

2.21

1.57

2.1

1.8

0.00

estimate

-0.00

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.11

1.55

1.0

1.1

2123.83

1581.49

miu/ml

1.19

(3027008) Opiates [Presence] in Urine

333

1.43

1.51

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

176

1491

1.21

1.51

3.3

4.2

47.62

19.72

ug/l

0.28

148

1218

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.86

1.50

2.0

10.77

18.88

umol/l

—

(4268621) Lupus anticoagulant assay

131

1.69

1.50

3.0

2.2

—

(44813793) Dust mix specific IgE antibody measurement

1.91

1.49

1.1

—

(3028300) Cannabinoids [Presence] in Urine

335

1.42

1.47

1.6

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

197

1.53

1.41

1.2

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.18

1.40

1.1

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

134

1.65

1.39

1.1

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

211

0.52

1.38

1.0

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

331

1.40

1.38

1.6

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

215

1.50

1.36

1.1

40.04

19.67

au/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

159

1349

1.20

1.36

3.0

2.3

33.98

36.32

u/l

0.32

144

1122

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.88

1.34

1.1

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.32

0.0

2.3

—

2.34

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

334

1.39

1.32

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

141

1188

1.21

1.30

1.8

1.7

1.49

1.46

0.28

116

1023

(3047352) Trisomy 18 risk [Likelihood] in Fetus

176

0.51

1.28

1.0

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.09

1.28

1.8

2.0

20.21

192.99

ug/l

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

130

1.62

1.27

1.1

93.05

95.24

0.14

121

(3022689) Creatine [Moles/volume] in Urine

2.29

1.27

1.6

4.57

7.12

mmol/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.29

1.27

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

170

1.54

1.26

1.4

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1233

12053

1.17

1.25

6.0

5.4

5.78

5.92

mmol/l

3.75

1104

10957

(3003740) Influenza virus B Ag [Presence] in Specimen

195

1.50

1.25

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

1.87

1.24

1.2

1.3

0.84

1.07

nmol/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.64

1.21

1.0

1.1

0.02

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.64

1.21

1.2

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.31

1.18

1.2

1.7

1.21

1.17

mmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.94

1.17

1.8

3.6

1.05

1.29

0.28

(3013637) Mi-2 Ab [Presence] in Serum

2.01

1.16

1.4

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.01

1.16

1.4

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.01

1.16

1.4

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.01

1.16

1.4

1.1

—

(3005570) Glucose [Moles/volume] in Urine

142

1.56

1.14

2.6

2.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.69

1.14

1.0

254.30

323.87

ng/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.34

1.12

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

161

1.50

1.07

1.2

1.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

220

1.42

1.05

2.0

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

952

0.81

1.05

2.3

3.6

45.24

80.21

u/ml

0.80

923

(3008536) Aspergillus sp Ab [Presence] in Serum

2.28

1.03

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.69

1.01

1.5

1.3

0.55

1.12

promille

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.00

1.00

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

1.72

0.99

7.2

3.0

0.62

0.75

index

0.31

(3019832) Treponema pallidum Ab [Presence] in Serum

107

908

1.19

0.97

1.8

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

109

1.57

0.93

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

382

3546

1.11

0.93

1.5

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

176

1.43

0.91

2.1

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1075

0.84

0.90

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

254

0.67

0.89

1.1

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

230

0.65

0.89

1.1

1.6

76.12

58.67

ug/l

—

193

(3034274) Bile acid [Moles/volume] in Serum --fasting

127

1.50

0.88

4.4

2.0

7.54

7.94

umol/l

0.05

(3043238) Trisomy 21 risk [Likelihood] in Fetus

181

0.60

0.88

1.0

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1178

11543

1.12

0.87

4.8

4.4

1.27

1.26

mmol/l

0.16

1053

10456

(40768793) Breast Pathology biopsy report

468

0.76

0.85

1.2

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.57

0.84

1.0

612.00

709.41

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.57

0.84

1.0

23.44

45.40

ng/l

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

129

1.48

0.83

1.8

1.7

—

2512.00

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

376

0.74

0.83

1.1

1.6

1135.22

955.32

mu/l

0.22

313

(4281824) Cell count and differential, peritoneal fluid

199

0.65

0.78

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.50

0.77

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

332

1.27

0.76

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

232

2123

1.11

0.75

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.65

0.75

2.1

1.1

—

(3049717) Cytology report of Urine Cyto stain

425

1.23

0.73

2.1

2.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

555

0.80

0.72

2.0

1.8

—

(4034850) Laboratory test

399

1.24

0.71

15.5

10.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

318

1.27

0.71

3.4

3.5

0.87

0.82

nmol/l

0.30

261

(3051611) Lipemic interference index of Serum or Plasma

143

1.40

0.70

5.8

2.8

15.23

12.13

index

0.41

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.54

0.67

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

504

1.20

0.66

1.4

1.6

35.03

15.06

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

277

1.27

0.65

1.9

1.7

0.88

0.83

nmol/l

0.17

225

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.59

0.65

1.0

1.2

10.86

8.95

mm/h

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

190

1.32

0.63

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

191

1751

1.10

0.62

5.5

5.4

3.07

2.43

ug/l

0.44

165

1563

(3047189) Immunofixation for 24 hour Urine

1.59

0.62

3.0

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.59

0.62

1.1

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

140

0.64

0.60

1.2

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

227

1.28

0.60

1.2

1.1

5.42

1.95

u/ml

0.39

130

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.63

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.54

0.59

1.5

1.2

85.89

103.31

nmol/l

—

(1002224) Polysomnography panel

507

0.82

0.58

1.1

—

(4198724) Urine methamphetamine measurement

1.62

0.55

1.0

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

571

5498

1.06

0.55

2.1

2.0

1.32

1.33

mmol/l

0.11

451

4588

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.58

0.54

1.0

1.1

—

975.00

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

338

0.79

0.53

2.0

1.2

0.90

0.91

g/l

0.10

338

(3043410) Blood group antigens tested for on Red Blood Cells

1.54

0.53

1.8

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

158

0.69

0.52

1.5

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

110

1.37

0.49

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.45

0.48

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.45

0.48

1.3

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

708

0.87

0.47

1.0

—

(3019150) Specific gravity of Urine by Refractometry

330

3138

1.07

0.47

7.1

4.5

1.02

1.50

kg/l

0.50

228

2101

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.47

0.47

1.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1001

0.89

0.46

2.5

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

418

0.83

0.46

1.7

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

153

0.72

0.45

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

138

1.31

0.45

1.3

1.8

—

(40768795) Lymph node Pathology biopsy report

152

0.72

0.44

1.4

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.61

0.43

1.8

1.3

—

(44806420) Estimation of glomerular filtration rate

131

1.30

0.42

2.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

194

1.24

0.42

1.1

0.20

4.32

u/ml

—

109

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.36

0.41

1.2

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.36

0.41

1.8

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.41

0.0

1.7

—

16.00

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.41

0.0

2.9

—

0.81

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

616

1.13

0.40

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.41

0.39

2.0

1.8

2.40

2.72

u/field

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.38

1.0

1.2

—

(3024263) Appearance of Synovial fluid

1.35

0.38

1.6

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

1.33

0.37

1.1

1.2

0.23

4.28

nmol/l

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

122

0.74

0.35

3.6

2.1

13.92

13.21

—

122

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.40

0.35

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

181

1.22

0.34

8.6

5.3

345.56

356.23

umol/l

0.09

163

(3044007) Cell count panel - Peritoneal fluid

1.28

0.32

1.7

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

176

0.79

0.32

1.4

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

944

0.92

0.31

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

124

1322

0.93

0.30

1.4

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

129

0.77

0.28

1.1

1.6

51.68

54.10

ug/l

—

129

(4024509) Urine culture

701

1.09

0.27

2.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.23

0.27

1.3

5.2

—

47.17

—

(3025130) Human papilloma virus identified in Specimen

197

1.17

0.26

1.8

—

(3008898) HLA-B27 [Presence]

425

1.11

0.25

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.23

0.25

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.22

0.25

1.4

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.74

0.22

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

0.74

0.22

1.9

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

238

1.14

0.22

1.9

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.22

0.22

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

6.34

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

1.16

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.4

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

37.72

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

7.36

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

19.60

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.60

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.21

0.0

2.0

—

0.03

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.21

0.0

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.39

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.05

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

9.49

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.9

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.01

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

185

1.14

0.18

1.1

0.52

1.99

u/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.21

0.17

1.5

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

129

1.16

0.17

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.72

0.17

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

183

0.87

0.16

1.3

1.6

—

(3022621) pH of Urine by Test strip

115

1103

1.05

0.16

3.6

3.1

6.20

6.08

0.85

767

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.15

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1214

12082

1.03

0.15

5.8

5.2

1.57

1.53

mmol/l

2.01

1096

11076

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

100

1039

0.96

0.13

3.2

0.77

0.74

ug/l

0.15

651

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

905

0.96

0.12

2.4

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

237

2418

0.98

0.11

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

430

4354

0.98

0.10

3.7

3.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

280

0.93

0.10

5.0

4.0

25.81

24.89

mg/l

0.05

192

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.11

0.09

1.4

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

186

0.91

0.09

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

478

1.05

0.09

1.4

1.5

0.38

0.33

mg/l

0.16

189

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

478

1.05

0.09

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1241

12374

1.02

0.09

6.4

6.1

2.58

2.70

mmol/l

4.79

1126

11378

(4211845) Urine protein measurement

0.77

0.08

7.6

4.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

154

0.91

0.08

1.3

1.1

3.43

2.89

u/ml

—

(4146454) Self-monitoring of blood glucose

156

1.09

0.08

3.5

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.06

0.08

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.05

0.08

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

510

0.96

0.07

1.6

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.07

0.07

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

354

1.05

0.06

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

535

1.03

0.05

2.2

3.1

414.41

735.15

u/ml

0.36

465

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

433

0.97

0.04

1.6

1.7

10.00

4.96

mg/l

0.74

326

(3010726) Horse dander IgE Ab [Units/volume] in Serum

180

0.94

0.04

1.3

1.1

8.37

1.56

u/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

329

1.03

0.03

5.5

4.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

139

0.93

0.03

1.3

1.1

13.73

6.63

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

128

0.94

0.02

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

338

0.98

0.01

1.4

1.3

186.71

250.57

miu/ml

0.55

150

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1217

12161

1.01

0.01

5.8

5.3

4.62

4.68

mmol/l

1.31

1101

11234

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

583

1.01

0.01

1.9

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

136

1.03

0.00

1.2

1.3

1.84

1.38

nmol/l

0.90

117

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

140

1398

1.00

0.00

4.5

4.6

21.96

21.51

0.14

664

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.10

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

369.14

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

1.00

-0.00

1.0

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3006462) Nitrate [Presence] in Urine

0.85

-0.00

7.6

4.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.91

-0.00

1.2

1.4

7.76

8.85

mmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

13.3

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

3.6

—

11.44

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

1.8

—

31.44

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

73.92

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

76.78

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPOPARA and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPOPARA	1.606 [1.43, 1.81]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.323

During the follow-up period (1.1.1998 — 31.12.2019), 1113 out of 4177 females with E4_HYPOPARA died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPOPARA	2.355 [1.88, 2.95]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 395 out of 1066 males with E4_HYPOPARA died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPOPARA.

N-year risk	Females	Males
1	0.192%	0.59%
5	1.074%	2.882%
10	2.494%	7.055%
15	4.443%	13.555%
20	7.481%	22.969%

Relationships between endpoints

↥

Index endpoint: E4_HYPOPARA – Hypoparathyroidism

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypoparathyroidism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints